Table 2.

Comparison of laboratory parameters in SFTS patients before and after IVIG treatment.

Variable	Before IVIG	After IVIG	P-value
WBC count, median (IQR), ×109/L	2.6 (1.6–4.3)	4.9 (3.4–7.4)	<0.001
ANC count, median (IQR), ×109/L	1.8 (1.1–2.9)	3.2 (2.0–6.1)	<0.001
ALC count, median (IQR), ×109/L	0.5 (0.4–0.7)	0.8 (0.6–1.2)	<0.001
NLR, median (IQR)	2.6 (1.6–6.5)	3.8 (2.0–6.8)	0.318
RDW, median (IQR), ×109/L	13.2 (12.8–14.0)	13.8 (12.9–14.4)	<0.001
PLT count, median (IQR), ×109/L	43.0 (32.2–60.0)	72.0 (31.8–122.8)	<0.001
PLR, median (IQR)	81.3 (41.7–145.0)	70.7 (38.8–163.3)	0.940

WBC, white blood cell; ANC, absolute neutrophil count; ALC, absolute lymphocyte count; NLR, neutrophil-to-lymphocyte ratio; RDW, red cell volume distribution width; PLT, platelet; PLR, platelet-to-lymphocyte ratio; IVIG, intravenous immunoglobulin; IQR, interquartile range.